National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences

Fox-Fordyce disease



Other Names:
Miliaria, apocrine; Apocrine miliaria; Fox-Fordyce syndrome
Categories:

Fox-Fordyce disease is a chronic skin disease most common in women aged 13-35 years.[1] It is characterized by the development of intense itching in the underarm area, the pubic area, and around the nipple of the breast as a result of perspiration which becomes trapped in the sweat gland and surrounding areas.[2] The cause is unknown, but heat, humidity, and stress may play a role. Treatment may include the use of retinoids, antibiotics, and immunosuppressants.[1][3]
Last updated: 8/3/2016

Individuals with Fox-Fordyce disease should consult with a dermatologist regarding treatment. Some of the recent treatments for the FFD include:  interlesional glucocorticoids, topical steroids, oral and topical retinoids, topical clindamycin, topical pimecrolimus cream, benzoyl peroxide, oral antibiotics and contraceptives or antiandrogenic hormonal therapy.[4][3]  Pimecrolimus and tacrolimus, both with significant anti-inflammatory activity and low side-effects, have provided rapid improvement in a limited number of cases.[1]  Other forms of treatment used are ultraviolet radiation (phototherapy), dermabrasion, liposuction and surgical excision.[4]  Immunosuppressants have been utilized with modest success.  For individuals who do not respond to medications, destruction or removal of the apocrine sweat glands (glands that surround hair follicles) has been effective in some cases. [4]
Last updated: 8/1/2014

These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.

Where to Start

  • DermNet NZ is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.
  • The National Organization for Rare Disorders (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.

In-Depth Information

  • Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
  • The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
  • PubMed is a searchable database of medical literature and lists journal articles that discuss Fox-Fordyce disease. Click on the link to view a sample search on this topic.

Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know. Submit a new question

  • How is Fox-Fordyce disease treated? Are there over-the-counter drugs that will help? What can I do for maintanence? See answer



  1. Christopher R Gorman. Fox-Fordyce Disease. Medscape. Sep 23, 2015; http://emedicine.medscape.com/article/1070560-overview.
  2. Timothy H. McCalmont. Fox Fordyce Disease. National Organization for Rare Disorders (NORD). 2010; http://rarediseases.org/rare-diseases/fox-fordyce-disease/.
  3. Vanessa Ngan. Fox-fordyce disease. DermNet New Zealand. 2005; http://dermnetnz.org/topics/fox-fordyce-disease/.
  4. Yost, J., Robinson, M., & Meehan, S. A. Fox-Fordyce disease. Dermatology online journal. 2012; 18(12):http://escholarship.org/uc/item/6km4c88v. Accessed 7/31/2014.